Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-03-13

Clinical Trial Update: Nutraceutical Supplement in the Management of Hypertension [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update for a nutraceutical supplement being studied for hypertension management.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nutraceutical supplement (investigational)

Snippet

Sponsor: Thorne HealthTech, Inc | Conditions: Hypertension | Phase 1, Phase 2 | Status: COMPLETED